Buchumschlag

Correlation of Endostatin and Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Serum Levels With Cardiovascular Involvement in Systemic Sclerosis Patients

Fibrosis of oesophagus, lungs, heart, and kidney in the course of systemic sclerosis (SSc) may lead to dysfunction of the above organs or even patients death. Recent studies point out the role of angiogenesis and fibrosis disturbances in the pathogenesis of SSc. Heart fibrosis is one of the most imp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Bozena Dziankowska-Bartkowiak (VerfasserIn), Elzbieta Waszczykowska (VerfasserIn), Anna Zalewska (VerfasserIn), Anna Sysa-Jedrzejowska (VerfasserIn)
Format:	Buch
Veröffentlicht:	Hindawi Limited, 2005-01-01T00:00:00Z.
Schlagworte:	article
Online-Zugang:	Connect to this object online.
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement
von: Bozena Dziankowska-bartkowiak, et al.
Veröffentlicht: (2003)

The Imbalance Between Metalloproteinases and Their Tissue Inhibitors Is Involved in the Pathogenesis of Dermatitis Herpetiformis
von: Agnieszka Zebrowska, et al.
Veröffentlicht: (2005)

The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid
von: Arleta Waszczykowska, et al.
Veröffentlicht: (2020)

Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis
von: Małgorzata Kobusiak-Prokopowicz, et al.
Veröffentlicht: (2021)

Genotype and haplotype analysis of ABCB1 at 1236, 2677 and 3435 among systemic sclerosis patients
von: Małgorzata Barańska, et al.
Veröffentlicht: (2017)

Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
von: Uldbjerg Niels, et al.
Veröffentlicht: (2008)

Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and -2) in the bovine corpus luteum
von: Moses Marsha A, et al.
Veröffentlicht: (2003)

Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure
von: Gialafos J. Elias, et al.
Veröffentlicht: (2008)

Estimation of SLE Activity Based on the Serum Level of Chosen Cytokines and Superoxide Radical Generation
von: Elzbieta Waszczykowska, et al.
Veröffentlicht: (1999)

Expression of matrix metalloproteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in oral submucous fibrosis
von: Rajendran R, et al.
Veröffentlicht: (2006)

Expression of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors (TIMPs) in Frozen Sperm of Rabbit
von: Sang Hwan Kim, et al.
Veröffentlicht: (2019)

Urinary Metalloproteinases-9 and -2 and Their Inhibitors TIMP-1 and TIMP-2 are Markers of Early and Long-Term Graft Function After Renal Transplantation
von: Ewa Kwiatkowska, et al.
Veröffentlicht: (2016)

Acroosteolysis of distal phalanges in patient with systemic sclerosis - case report
von: Zofia Gerlicz-Kowalczuk, et al.
Veröffentlicht: (2016)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
von: A. V. Chepets
Veröffentlicht: (2015)

Hyperhidrosis: causes and treatment options
von: Olga Jabłonowska, et al.
Veröffentlicht: (2020)

Serum Levels of Tissue Inhibitors of Metalloproteinase 2 in Patients With Systemic Sclerosis With Duration More Than 2 Years: Correlation With Cardiac and Pulmonary Abnormalities
von: Amira Shahin, et al.
Veröffentlicht: (2006)

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure
von: Nissi Ritva, et al.
Veröffentlicht: (2013)

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus
von: Ewa Robak, et al.
Veröffentlicht: (2006)

Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells
von: Allison Grenell, et al.
Veröffentlicht: (2024)

Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma
von: Talvensaari-Mattila Anne, et al.
Veröffentlicht: (2010)

Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
von: Lucia Saucedo, et al.
Veröffentlicht: (2021)

Neuropsychotoxicity of Abused Drugs: Involvement of Matrix Metalloproteinase-2 and -9 and Tissue Inhibitor of Matrix Metalloproteinase-2 in Methamphetamine-Induced Behavioral Sensitization and Reward in Rodents
von: Hiroyuki Mizoguchi, et al.
Veröffentlicht: (2008)

Systemic sclerosis - diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 2: treatment
von: Dorota Krasowska, et al.
Veröffentlicht: (2017)

IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid
von: Agnieszka Zebrowska, et al.
Veröffentlicht: (2013)

The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?
von: Wei Gong, et al.
Veröffentlicht: (2021)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
von: Natheer Hashim Al-Rawi, et al.
Veröffentlicht: (2014)

Use of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in the pathomorphological diagnosis of carotid pathology: literature review and own observations
von: Yu. I. Kuzyk
Veröffentlicht: (2016)

Endostatin in Renal and Cardiovascular Diseases
von: Mei Li, et al.
Veröffentlicht: (2021)

Clinical significance of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and 2 in Kawasaki disease
von: Ki Wook Yun, et al.
Veröffentlicht: (2010)

High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment
von: Halina Urbanska-Rys, et al.
Veröffentlicht: (2003)

Pharmacokinetics and Biodistribution of Human Serum Albumin-TIMP-2 Fusion Protein Using Near-Infrared Optical Imaging
von: Mi-Sook Lee, et al.
Veröffentlicht: (2011)

Interleukin 6 and 8 Levels in Plasma and Fibroblast Cultures in Psoriasis
von: Anna Zalewska, et al.
Veröffentlicht: (2006)

Activity of matrix metalloproteinases and their tissue inhibitors in serum in chronic granulating periodontitis
von: D. I. Haidash, et al.
Veröffentlicht: (2019)

Evaluation of effect of propranolol on serum vascular endothelial growth factor and tissue inhibitor of metalloproteinase-2 levels in infantile hemangioma
von: Anand Pandey, et al.
Veröffentlicht: (2020)

Matrix Metalloproteinases in patients with Multiple Sclerosis.
von: Rebeca A. Fernández Carriera, et al.
Veröffentlicht: (2007)

Matrix Metalloproteinases in patients with Multiple Sclerosis.
von: Rebeca A. Fernández Carriera, et al.
Veröffentlicht: (2007)

Circulating TCR γδ Cells in the Patients with Systemic Lupus Erythematosus
von: Ewa Robak, et al.
Veröffentlicht: (1999)

The Role of Matrix Metalloproteinase2 (MMP2) in Serum and Peritoneal Fluid of Endometriotic Patients
von: NurIedil Baharuddin, et al.
Veröffentlicht: (2018)

The Imbalance in Serum Concentration of Th-1- and Th-2-Derived Chemokines as One of the Factors Involved in Pathogenesis of Atopic Dermatitis
von: Joanna Narbutt, et al.
Veröffentlicht: (2009)

The potential use of Endostatin and Angiopoietin-2 as valuable biomarkers for the prediction of Diabetic Nephropathy in Type 2 Diabetes Mellitus
von: Mohamed Salem, et al.
Veröffentlicht: (2019)